Deadline: 11-Jun-25
The Novo Nordisk Foundation is seeking proposals for basic and clinical research within the endocrine system and metabolism relating to cellular energy homeostasis.
The purpose is to promote Nordic research at the highest international level to carry out research projects of 1-3 years duration.
Areas of Support
- The overall goal is to obtain knowledge and/or better treatment or prevention relevant to the human organism within the area of endocrinology and metabolism, relating to cellular energy homeostasis, and hormonal disorders of the endocrine system.
- Areas supported include research involving patients and/or clinical practice but could also include animal models, model organisms, cellular or sub-cellular systems (with clear whole body relevance) as well as in silico analysis, with the overall purpose of solving challenges related to endocrinology and metabolism in health and disease.
- Projects within cancer research will not be approved, but projects on e.g., endocrine tumours where the topic is focused on signalling or cross-talk (not strictly related to cancer development) will be taken into consideration.
Funding Information
- A total of up to DKK 103 million is available for projects lasting from 1 to 3 years. Projects of up to DKK 4 million can be applied for with a yearly maximum budget of DKK 1.4 million.
- The budget allocated to the first year can be higher than DKK 1.4 million if equipment purchases are required for the project.
Eligibility Criteria
- Geography and institutions:
- The administrating institution must be a university, hospital or other non-profit research institution in Denmark, Finland, Iceland, Norway, or Sweden.
- Applicants must be experienced independent researchers, who have already established their own line of research or are in the process of establishing themselves as independent researchers. The applicant must be the clear driver of the project.
Ineligibility Criteria
- Applications from Ph.D. students and postdocs will not be taken into consideration.
- Co-applicants are not allowed within this call.
Assessment Criteria
- The Novo Nordisk Foundation’s Committee on Endocrinology and Metabolism will primarily assess the applications based on the following criteria:
- Scientific originality and relevance
- Scientific or broader societal impact
- Scientific approach
- Scientific environment and collaboration
- Background and expertise (relative to career stage) of the applicant.
For more information, visit Novo Nordisk Foundation.